Drug
Ambroxol clinical trials
- studies test it
- 21
- open now
- 7
- in phase 3
- 5
- first study started
- 2005
Keep track of what changes. Save the Ambroxol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
21 studies that test it; most in 2023 (4)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 14
- Phase 3
- 5
- Phase 4
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 14
Boehringer Ingelheim (3) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2) · Agyany Pharma LTD (2) · University College, London (2) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1) · National University of Malaysia (1) · Shaare Zedek Medical Center (1) · Hull University Teaching Hospitals NHS Trust (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Ambroxol is read from its arms, and is right about nine times in ten.
Testing it · 21
- Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical TrialRecruitingPhase 2Helse FonnaNCT04588285Written as Ambroxol
- An Open Label Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacologic Properties of High Dose Ambroxol Hydrochloride in Adult (≥ 18 Years of Age) Subjects With MPS IIIRecruitingPhase 2/3Ozlem Goker-AlpanNCT06614894Written as Ambroxol Hydrochloride 30 mg tablet - 9 mg/kg/day
- Ambroxol to Slow Progression in Parkinson DiseaseRecruitingPhase 3University College, LondonNCT05778617Written as Ambroxol Hydrochloride (420mg)
- High-Dose Ambroxol in GBA1-Related ParkinsonRecruitingPhase 1/2Agyany Pharma LTDNCT06193421Written as Ambroxol Hydrochloride
- Ambroxol as a Novel Disease Modifying Treatment for Lewy Body DementiaNot yet recruitingPhase 1/2London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sNCT04405596Written as Ambroxol Hydrochloride
- A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALSRecruitingPhase 2The Florey Institute of Neuroscience and Mental HealthNCT05959850Written as Ambroxol
- GRoningen Early-PD Ambroxol TreatmentRecruitingPhase 2/3University Medical Center GroningenNCT05830396Written as Ambroxol Hydrochloride
- High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)CompletedNot applicableAgyany Pharma LTDNCT07285369Written as Ambroxol
- Ambroxol as a Disease-modifying Treatment in GBA-PDCompletedPhase 2Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaNCT05287503Written as Ambroxol Hydrochloride
- Ambroxol as a Treatment for Parkinson's Disease DementiaActive, not recruitingPhase 2London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sNCT02914366Written as Ambroxol
- Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill PatientsCompletedPhase 4National University of MalaysiaNCT05663905Written as Ambroxol Hydrochloride
- Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement TherapyCompletedPhase 2Shaare Zedek Medical CenterNCT03950050Written as Ambroxol
- Effect of Ambroxol in Diabetic Peripheral NeuropathyStatus unknownNot applicableAin Shams UniversityNCT05558878Written as Ambroxol Oral Product
- Ambroxol in Disease Modification in Parkinson DiseaseCompletedPhase 2University College, LondonNCT02941822Written as Ambroxol
- Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore ThroatCompletedPhase 3Boehringer IngelheimNCT00525044Written as Ambroxol
- A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough.CompletedPhase 2Hull University Teaching Hospitals NHS TrustNCT03415269Written as Ambroxol Hydrochloride
- Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/ViralpharyngitisCompletedPhase 3Boehringer IngelheimNCT00148499Written as Ambroxol hydrochloride (Mucoangin?)
- Effects of Oral Mucolytics on Tear Film and Ocular SurfaceCompletedPhase 1/2Hallym University Kangnam Sacred Heart HospitalNCT01713179Written as Ambroxol hydrochloride (Mucopect®, 60 mg, Boehringer Ingelheim)
- Ambroxol Spray Sore Throat StudyCompletedPhase 2Boehringer IngelheimNCT01361802Written as Ambroxol Spray
- Clinical Trial of Ambroxol in Patients With Type I Gaucher DiseaseSuspendedPhase 1/2Exsar CorporationNCT01463215Written as Ambroxol
See all 21 studies that test Ambroxol →
Given in every arm · 1 — Ambroxol is usual care beside what is tested
As the comparator · 1 — what is tested is compared with Ambroxol
Codes
What other systems call Ambroxol · ClinicalTrials.gg INT006938
- MeSH (NLM) D000551AmbroxolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 200168S0CLAMBROXOLConfirmed FDA, NLM, Wikidata
- RxNorm 625Confirmed FDA, Wikidata
- Wikidata Q221637ambroxolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74262AmbroxolOne source FDA
- DrugBank DB06742One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000551 | Ambroxol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 200168S0CL | AMBROXOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 625 | — | Confirmed FDA, Wikidata |
| Wikidata | Q221637 | ambroxol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74262 | Ambroxol | One source FDA |
| DrugBank | DB06742 | — | One source Wikidata |
Also registered as ambroxol hydrochloride (UNII CC995ZMV90 · RxNorm 438399).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.